Related Experiment Video
Updated: Jul 31, 2025

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
Published on: January 20, 2019
EBNA1 Upregulates P53-Inhibiting Genes in Burkitt's Lymphoma Cell Line
Seyed Mohammad Ali Hashemi1, Abdolvahab Moradi1, Seyed Younes Hosseini2
1Department of Microbiology, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
Background:
Suppression of p53 is an important mechanism in Epstein-Barr virus associate-tumors and described as EBNA1-USP7 which is a key axis in p53 suppression. Thus, in this study, we aimed to evaluate the function of EBNA1 on the expression of p53-inhibiting genes including HDAC-1, MDM2, MDM4, Sirt-3, and PSMD10 and the influence of USP7 inhibition using GNE-6776 on p53 at protein/mRNA level.
Methods:
The electroporation method was used to transfect the BL28 cell line with EBNA1. Cells with stable EBNA1 expression were selected by Hygromycin B treatment. The expression of seven genes, including PSMD10, HDAC-1, USP7, MDM2, P53, Sirt-3, and MDM4, was evaluated using a real-time PCR assay. For evaluating the effects of USP7 inhibition, the cells were treated with GNE-6776; after 24 hours and 4 days, the cells were collected and again expression of interest genes was evaluated.
Results:
MDM2 (P=0.028), MDM4 (P=0.028), USP7 (P=0.028), and HDAC1 (P=0.015) all showed significantly higher expression in EBNA1-harboring cells compared to control plasmid transfected cells, while p53 mRNA expression was only marginally downregulated in EBNA1 harboring cells (P=0.685). Four-day after treatment, none of the studied genes was significantly changed. Also, in the first 24-hour after treatment, mRNA expression of p53 was downregulated (P=0.685), but after 4 days it was upregulated (P=0.7) insignificantly.
Conclusion:
It seems that EBNA1 could strongly upregulate p53-inhibiting genes including HDAC1, MDM2, MDM4, and USP7. Moreover, it appears that the effects of USP7 suppression on p53 at protein/mRNA level depend on the cell nature; however, further research is needed.
Insights
Epstein-Barr virus nuclear antigen 1 (EBNA1) upregulates p53-inhibiting genes like HDAC1, MDM2, MDM4, and USP7. USP7 inhibition effects on p53 depend on cell type, requiring further investigation.
Area of Science:
- Molecular Biology
- Virology
- Cancer Research
Background:
- p53 suppression is crucial in Epstein-Barr virus (EBV)-associated tumors.
- The EBNA1-USP7 axis is a key player in p53 suppression.
- Understanding EBNA1's role in regulating p53-inhibiting genes is vital.
Purpose of the Study:
- To evaluate EBNA1's function on p53-inhibiting genes (HDAC1, MDM2, MDM4, Sirt-3, PSMD10).
- To assess the influence of USP7 inhibition using GNE-6776 on p53 expression.
- To investigate the EBNA1-USP7 interaction in the context of EBV-associated malignancies.
Main Methods:
- BL28 cell line transfection with EBNA1 via electroporation.
- Stable EBNA1 expression selection using Hygromycin B.
- Real-time PCR to evaluate gene expression (PSMD10, HDAC-1, USP7, MDM2, P53, Sirt-3, MDM4) pre- and post-GNE-6776 treatment.
Main Results:
- EBNA1 significantly upregulated MDM2, MDM4, USP7, and HDAC1 mRNA expression (P<0.05).
- p53 mRNA expression showed only marginal downregulation in EBNA1-harboring cells (P=0.685).
- USP7 inhibition with GNE-6776 did not significantly alter studied gene expression after 24 hours or 4 days.
Conclusions:
- EBNA1 strongly upregulates key p53-inhibiting genes: HDAC1, MDM2, MDM4, and USP7.
- The impact of USP7 suppression on p53 levels is cell-type dependent.
- Further research is necessary to elucidate the precise mechanisms and therapeutic potential.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
The Intrinsic Apoptotic Pathway
Mitogens and the Cell Cycle
Cell Specific Gene Expression
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...

